DISCOVER OMRON'S LATEST TECHNOLOGY
OMRON
OMRON Healthcare: Smart Health Management at home.
With over 90 years of expertise, OMRON Healthcare is a trusted global leader in clinically proven**, at-home health solutions. OMRON’s mission is to help you live a healthier, more confident life with smart, connected devices that make daily health management simple.
The OMRON range includes blood pressure monitors and ECG devices, TENS pain relief units, digital scales and body composition monitors, nebulisers – all designed for easy, reliable use at home. OMRON devices provide clinically validated accuracy^ you can trust. Some models offer special features such as clinical validation for pregnant women, people with diabetes type 2 and obesity**, plus connectivity for effortless tracking via the free, easy-to-use OMRON connect app†.
If you are concerned about heart health, OMRON’s blood pressure monitor range includes devices that help with early detection of atrial fibrillation (AFib), a leading cause of stroke†. Products like the M7 Intelli IT AFib, M4 Intelli IT AFib, and the Complete Blood Pressure Monitor with ECG support regular monitoring to help reduce stroke risk.
Build your own connected health routine with OMRON Healthcare smart ecosystem, designed to help you manage your health at home with confidence, every day.
*Gutierrez C. Blanchard DG. Diagnosis and Treatment of Atrial Fibrillation. Am Fam Physician. 2016 Sep 15,94(6)442-52.
**Clinically validated: https://www.stridebp.org/bp-monitors
^Same accuracy as in doctor’s surgery: O’Brien, E et al, European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults, Blood Pressure Monitoring: February 2010 - Volume 15 - Issue 1 - p 23-38. Available at https://journals.lww.com/bpmonitoring/Citation/2010/02000/.
^^https://www.omron-healthcare.co.uk/omronconnect
†Lei N, et al. Hybrid Decision Support to Monitor Atrial Fibrillation for Stroke Prevention. Int J Environ Res Public Health. 2021 Jan 19;18(2):813.
